Top Analyst Calls: Intuitive Surgical, Salesforce Price Targets Raised
Thursday saw a wave of analyst updates, notably raising price targets for Intuitive Surgical (ISRG) and Salesforce (CRM), with buy ratings backed by strong fundamentals.
Thursday saw a wave of analyst updates on Wall Street, with notable price target increases for Intuitive Surgical (ISRG) and Salesforce (CRM), reflecting cautious optimism on their growth trajectories.
Rating Changes
Analysts raised the price target for Intuitive Surgical from $550 to $620, maintaining a "Buy" rating. For Salesforce, the target was lifted from $320 to $360, with an "Overweight" rating.
Analyst Rationale
Intuitive Surgical benefits from rising demand for robotic surgery, with procedure volumes growing 15% year-over-year last quarter. Salesforce is supported by its generative AI investments, boosting cloud product sales.
Context
The updates come amid mixed stock performance: ISRG rose 8% over the past month, while CRM fell 3%. Other analysts hold varied views, but the consensus remains positive.
Bottom Line
The calls reflect confidence in both companies' ability to grow despite economic headwinds. However, investors should assess sector-specific risks before acting.
Frequently Asked Questions
Found this useful? Share it